2020-12-03 08:22 Overview Target Indication Mechanism of Action Status Drug Name CD3xCD20 bsAb Description Anti-CD3/CD20 bispecific antibody (CD3xCD20 bsAb) is able to bring T cells to tumor microenvironment. Experiments demonstrated that low-toxic CD3xCD20 bsAb has ... дальше
2020-12-03 08:22 Overview Target Drug Modality Indication Mechanism of Action Status Data Drug Name CD3xBCMA-bsAb Description CD3xBCMA-bsAb, a novel bispecific antibody concomitantly targeting BCMA, highly expressed on multiple myeloma (MM) cells, and CD3 on T cells, ... дальше
2020-12-03 08:21 Overview Target Drug Modality Indication Mechanism of Action Status Data Drug Name Compound-0056 Description VISTA, or V-type immunoglobulin domain-containing suppressor of T-cell activation, is a negative checkpoint regulator expressed on naïve T ce ... дальше
